Filing Details

Accession Number:
0001114220-18-000100
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-10-30 16:07:47
Reporting Period:
2018-10-29
Accepted Time:
2018-10-30 16:07:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1114220 Keryx Biopharmaceuticals Inc KERX Pharmaceutical Preparations (2834) 134087132
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1640447 F. John Neylan C/O Keryx Biopharmaceuticals, Inc.
One Marina Park Drive, 12Th Floor
Boston MA 02210
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-10-29 1,253 $3.07 149,435 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Sale of a total of 1,253 shares of common stock was made in order to satisfy Mr. Neylan's income tax withholding obligation upon the vesting of 4,479 shares of restricted stock on October 28, 2018. Mr. Neylan had no discretion with respect to such sale, which was transacted in accordance with the Issuer's corporate policies regarding the vesting of restricted stock.
  2. Includes 70,102 shares of restricted stock.